[Pediatric angiocardiography. Randomized, controlled study of 2 iodinated contrast media: iopromide 300 and ioxaglate 320 mgI/ml].
Thirty-one children were included in a prospective randomized trial comparing a new non-ionic contrast medium, iopromide 300 and the ionic low osmolar contrast medium, ioxaglate 320 mgI/ml in pediatric cardiac catheterisation. There were fewer adverse effects with iopromide but no statistically significant difference was demonstrated in this small population, with a very low incidence of allergoïd reactions; this tendency was confirmed by meta-analysis of the multicentre study.